** Shares of Mach7 Technologies M7T.AX extend gains from the previous session to climb 8% to A$0.4
** Stock hits highest level since Nov 5, 2024
** The medical imaging systems provider posts contracted annual recurring revenue $(CARR)$ of A$31.8 mln ($19.76 mln) at Dec 31, up 15.6% from Sept 2024 levels
** Co reaffirms FY25 outlook for 15-25% growth in CARR
** Co announced on-market buyback programme of up to A$5 mln on Thursday
** About 1.1 mln shares change hands, 2.5 times the 30-day average of share
** Stock down 7.5% this year, as of last close
($1 = 1.6095 Australian dollars)
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。